Preclinical and clinical evidence of nephro- and cardiovascular protective effects of glycosaminoglycans

Despite advances in pharmacological treatment, diabetic nephropathy is still the leading cause of end-stage renal disease and an important cause of morbidity and mortality in diabetics. Glycosaminoglycans are long, unbranched mucopolysaccharides that play an important role in establishing a charge-s...

Descripción completa

Detalles Bibliográficos
Autores principales: Cicero, Arrigo F., Ertek, Sibel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2010
Materias:
Review Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3284059/
https://www.ncbi.nlm.nih.gov/pubmed/22371788
http://dx.doi.org/10.5114/aoms.2010.14456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3284059/
https://www.ncbi.nlm.nih.gov/pubmed/22371788
http://dx.doi.org/10.5114/aoms.2010.14456

Ejemplares similares